Back

Impact of 2nd-generation versus 3rd-generation beta-blockers on long-term clinical outcomes in STEMI patients treated with drug-eluting stents

31 August 2025 (14:15 - 15:00)
Organised by: Logo
Congress Presentation Part of: Chronic coronary syndromes: prognosis Pharmacotherapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Melly Susanti

Ministry of Health Surabaya Central General Hospital, Jawa Timur (Indonesia)

7 More presentations in this session

Presentation thumbnail
In-hospital mortality in hemorrhagic myocardial infarction
Doctor K. Vora (Indianapolis, US)
Abstract Slides Video
Presentation thumbnail
Medical versus invasive management in patients with non-ST segment elevation myocardial infarction and prior coronary artery bypass grafting: which approach improves outcomes?
Doctor A. Fernandes (Braga, PT)
Abstract Slides Video
Presentation thumbnail
Five-year longitudinal assessment of cardiac allograft vasculopathy after heart transplantation using optical coherence tomography
Doctor M. Arai (Sendai, JP)
Abstract Slides Video
Presentation thumbnail
The impact of socioeconomic deprivation on the long-term survival of people with diabetes and acute myocardial infarction: a nationwide cohort study
Doctor N. Weight (Stoke-on-Trent, GB)
Abstract Slides Video
Presentation thumbnail
Predictors for change in quality of life in patients with chronic coronary syndrome undergoing PCI
Ms S. Janssen (Heerlen, NL)
Abstract Slides Video

Access the full session

Session thumbnail
Chronic coronary syndromes: prognosis

The Event

Event poster

ESC Congress 2025

31 August 2025 14:15 CET
You may be interested in
thumbnail
Congress Presentation
Impact of beta-blocker carvedilol versus Bisoprolol prescription at discharge on long-term clinical outcomes in STEMI patients with preserved LVEF treated with drug-eluting stents
thumbnail
Congress Presentation
Impact of beta-blocker nebivolol versus carvedilol prescription at discharge on long-term clinical outcomes in STEMI patients with reduced LVEF treated with drug-eluting stents
thumbnail
Congress Presentation
Impact of beta-blocker Nebivolol versus Carvedilol prescription at discharge on long-term clinical outcomes in STEMI patients with preserved LVEF treated with drug-eluting stents

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources